You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

vismodegib

( VIS-mo-DEG-ib )
Funding:
Exceptional Access Program
  • vismodegib - Treatment for metastatic basal cell carcinoma (BCC) or with locally advanced BCC (including patients with basal cell nevus syndrome, i.e. Gorlin syndrome), according to specific criteria
Other Name(s): Erivedge®
Appearance: capsule

Patient Info Sheet

Jun 2017

What it is used for

  • For treating a type of skin cancer (basal cell carcinoma) not appropriate for surgery or radiotherapy, or has spread to other parts of the body


You might also be interested in